Metagenomi

Historical price data

Metagenomi is a clinical-stage biotechnology company leveraging its proprietary metagenomics discovery platform to unearth novel genome editing systems from nature's microbial diversity. The company has built a massive proprietary database and uses AI-enabled screening to identify and engineer compact, efficient editors, advancing a pipeline of in vivo genetic medicines. Its strategy focuses on high-value programs in diseases with clear biology and regulatory paths, while also pursuing platform partnerships to expand the reach of its technology.

A proprietary metagenomics discovery platform that sequences environmental DNA to build a massive database, uses AI/ML for high-throughput screening, and employs modular engineering to develop novel CRISPR nucleases, base editors, and gene insertion systems for in vivo therapeutic applications.